[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:alopecia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":197,"states":198},"Alopecia",30,24,[8,16,23,29,35,41,47,54,60,66,72,78,85,91,97,104,110,116,122,128,134,140,146,152,158,165,171,178,184,190],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07533006","A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)",[12],"Phase 2","RECRUITING","2026-08-26T02:15:57.572488Z","2026-05-05T02:43:29.399467Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06873945","A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata",[20],"Phase 3","2026-08-26T02:15:52.238965Z","2026-05-05T02:43:29.390377Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05866562","Dupilumab in the Treatment of Pediatric Alopecia Areata",[12],"2026-08-26T02:17:17.791881Z","2026-05-05T02:43:29.055512Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05398809","Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata",[12],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:29.044102Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06012240","A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata",[20],"2026-08-26T02:18:56.409949Z","2026-05-05T02:43:29.029243Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07029828","A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.",[20],"2026-08-26T02:15:47.754948Z","2026-05-05T02:43:28.972789Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT07029204","Intralesional Cyclosporine for Alopecia Areata",[51],"Early Phase 1","2026-08-03T03:24:20.303158Z","2026-05-05T02:43:28.501469Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07311564","A Study of LAD603 in Adults With Alopecia Areata",[12],"2026-08-26T02:18:13.438956Z","2026-05-05T02:43:28.479801Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06885112","Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser",[],"2026-08-26T02:17:30.145302Z","2026-05-05T02:43:28.371185Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07041489","Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair",[],"2026-08-26T02:16:21.385056Z","2026-05-05T02:43:28.175387Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05723198","A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata",[20],"2026-08-26T02:15:59.318403Z","2026-05-05T02:43:27.110229Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":83,"content_modified":84},"NCT06826196","A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata",[82],"Phase 1\u002FPhase 2","2026-08-26T02:18:22.309547Z","2026-05-05T02:35:31.752243Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT05551793","Regeneron AA Multicenter (Dupilumab)",[12],"2026-08-26T02:18:07.037408Z","2026-05-05T02:35:31.712964Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT07215689","Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women\"",[],"2026-08-26T02:16:46.951087Z","2026-05-05T02:35:31.641195Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":102,"content_modified":103},"NCT07049328","HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata",[101],"Phase 1","2026-08-26T02:15:45.413021Z","2026-05-05T02:35:31.608247Z",{"nct_id":105,"title":106,"phases":107,"status":13,"updated_at":108,"content_modified":109},"NCT07133308","Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata",[20],"2026-08-26T02:19:26.493949Z","2026-04-29T02:57:57.118671Z",{"nct_id":111,"title":112,"phases":113,"status":13,"updated_at":114,"content_modified":115},"NCT06869252","Autologous Adipose Cells Therapy",[82],"2026-08-26T02:15:14.574786Z","2026-05-05T02:43:29.665204Z",{"nct_id":117,"title":118,"phases":119,"status":13,"updated_at":120,"content_modified":121},"NCT07242638","Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome",[12],"2026-08-26T02:19:30.857183Z","2026-05-05T02:43:27.399225Z",{"nct_id":123,"title":124,"phases":125,"status":13,"updated_at":126,"content_modified":127},"NCT06747611","Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata",[12],"2026-08-26T02:15:18.897219Z","2026-05-05T02:43:27.130353Z",{"nct_id":129,"title":130,"phases":131,"status":13,"updated_at":132,"content_modified":133},"NCT07733765","A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata",[20],"2026-08-26T02:16:10.529598Z","2026-07-30T01:46:14.453672Z",{"nct_id":135,"title":136,"phases":137,"status":13,"updated_at":138,"content_modified":139},"NCT06562270","CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry",[],"2026-08-26T02:16:55.892527Z","2026-05-13T02:55:06.510649Z",{"nct_id":141,"title":142,"phases":143,"status":13,"updated_at":144,"content_modified":145},"NCT06531109","Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib",[],"2026-08-26T02:16:47.762107Z","2026-05-13T02:55:06.498743Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT05745389","CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry",[],"2026-08-26T02:15:33.331531Z","2026-05-13T02:55:06.374903Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":156,"content_modified":157},"NCT06046651","Blood Specimen Collection For Laboratory Assay Research",[],"2026-08-26T02:18:33.598205Z","2026-05-13T02:55:06.405900Z",{"nct_id":159,"title":160,"phases":161,"status":162,"updated_at":163,"content_modified":164},"NCT07221773","Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning Hair",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:50.500039Z","2026-06-16T05:54:07.875730Z",{"nct_id":166,"title":167,"phases":168,"status":162,"updated_at":169,"content_modified":170},"NCT07224555","Study Evaluating Xtressé Gummy Supplement in Women With Self-Perceived Thinning Hair",[],"2026-08-26T02:17:49.709549Z","2026-06-16T05:54:07.874411Z",{"nct_id":172,"title":173,"phases":174,"status":175,"updated_at":176,"content_modified":177},"NCT07029711","A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:25:11.951163Z","2026-05-05T02:43:28.103027Z",{"nct_id":179,"title":180,"phases":181,"status":175,"updated_at":182,"content_modified":183},"NCT06602232","A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo",[101],"2026-08-03T02:07:10.948296Z","2026-05-05T02:43:27.861183Z",{"nct_id":185,"title":186,"phases":187,"status":175,"updated_at":188,"content_modified":189},"NCT07226531","Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US",[],"2026-08-03T02:15:30.195506Z","2026-05-13T02:55:06.678301Z",{"nct_id":191,"title":192,"phases":193,"status":194,"updated_at":195,"content_modified":196},"NCT05635266","Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives",[],"UNKNOWN","2026-08-03T02:15:56.082035Z","2026-05-13T02:55:06.368062Z",[],[199,203,207,211,215,218,221,224,228,231,235,238,241,245,248,251,254,257,261,264,267,271,274,278],{"state":200,"count":201,"slug":202},"California",16,"california",{"state":204,"count":205,"slug":206},"Florida",14,"florida",{"state":208,"count":209,"slug":210},"Maryland",11,"maryland",{"state":212,"count":213,"slug":214},"Indiana",10,"indiana",{"state":216,"count":213,"slug":217},"Michigan","michigan",{"state":219,"count":213,"slug":220},"New York","new-york",{"state":222,"count":213,"slug":223},"Texas","texas",{"state":225,"count":226,"slug":227},"Massachusetts",9,"massachusetts",{"state":229,"count":226,"slug":230},"Pennsylvania","pennsylvania",{"state":232,"count":233,"slug":234},"Illinois",7,"illinois",{"state":236,"count":233,"slug":237},"Oregon","oregon",{"state":239,"count":233,"slug":240},"Washington","washington",{"state":242,"count":243,"slug":244},"Alabama",6,"alabama",{"state":246,"count":243,"slug":247},"Nebraska","nebraska",{"state":249,"count":243,"slug":250},"North Carolina","north-carolina",{"state":252,"count":243,"slug":253},"Ohio","ohio",{"state":255,"count":243,"slug":256},"South Carolina","south-carolina",{"state":258,"count":259,"slug":260},"Georgia",5,"georgia",{"state":262,"count":259,"slug":263},"Minnesota","minnesota",{"state":265,"count":259,"slug":266},"Tennessee","tennessee",{"state":268,"count":269,"slug":270},"Utah",4,"utah",{"state":272,"count":269,"slug":273},"Wisconsin","wisconsin",{"state":275,"count":276,"slug":277},"Arizona",3,"arizona",{"state":279,"count":276,"slug":280},"Arkansas","arkansas"]